DKSH Holding Ltd DKSH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CHF 66.60
- Day Range
- CHF 66.20–67.70
- 52-Week Range
- CHF 55.30–69.10
- Bid/Ask
- CHF 63.50 / CHF 68.00
- Market Cap
- CHF 4.40 Bil
- Volume/Avg
- 103,644 / 58,726
Key Statistics
- Price/Earnings (Normalized)
- 21.91
- Price/Sales
- 0.40
- Dividend Yield (Trailing)
- 3.32%
- Dividend Yield (Forward)
- 3.32%
- Total Yield
- 3.39%
Company Profile
DKSH Holding Ltd offers market expansion services in Asia. The company's services include sourcing, marketing, sales, distribution, and after-sales service. DKSH operates in four business segments: Consumer goods, Healthcare, Performance Materials, and Technology. The maximum segment by revenue, Healthcare, specializes in expansion services such as product registration, marketing, distribution, and sales for pharmaceuticals, consumer health, and over-the-counter health products as well as medical devices.
- Sector
- Industrials
- Industry
- Consulting Services
- Stock Style Box
- Mid Core
- Total Number of Employees
- 27,062
- Website
- https://www.dksh.com
Comparables
Valuation
|
Metric
|
DKSH
|
HBMNE
|
BIOEE
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.91 | 37.43 | 4.49 |
Price/Book Value | 2.56 | 0.75 | 0.92 |
Price/Sales | 0.40 | 33.89 | 8.04 |
Price/Cash Flow | 12.98 | — | 22.31 |
Price/Earnings
DKSH
HBMNE
BIOEE
Financial Strength
|
Metric
|
DKSH
|
HBMNE
|
BIOEE
|
|---|---|---|---|
Quick Ratio | 0.94 | — | — |
Current Ratio | 1.35 | — | — |
Interest Coverage | 10.30 | — | — |
Quick Ratio
DKSH
HBMNE
BIOEE
Profitability
|
Metric
|
DKSH
|
HBMNE
|
BIOEE
|
|---|---|---|---|
Return on Assets (Normalized) | 3.90% | 1.92% | 8.82% |
Return on Equity (Normalized) | 12.89% | 2.10% | 10.04% |
Return on Invested Capital (Normalized) | 8.96% | — | — |
Return on Assets
DKSH
HBMNE
BIOEE
Consulting Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Experian PLC
EXPGF
| — | Gsyw | $48.1 Bil | |||
| Experian PLC ADR
EXPGY
| Cctmdsskb | Kswj | $48.1 Bil | |||
| Verisk Analytics Inc
VRSK
| Kfvkfgwnf | Zczxl | $37.6 Bil | |||
| Equifax Inc
EFX
| Wfpbxplyt | Blhlm | $35.9 Bil | |||
| SGS AG
SGSOF
| — | Jtmwp | $21.3 Bil | |||
| SGS AG ADR
SGSOY
| — | Ttgd | $21.3 Bil | |||
| Booz Allen Hamilton Holding Corp Class A
BAH
| — | Ydxk | $20.9 Bil | |||
| Bureau Veritas SA
BVRDF
| — | Knqhp | $15.1 Bil | |||
| Bureau Veritas SA ADR
BVVBY
| — | Xxqwx | $15.1 Bil | |||
| FTI Consulting Inc
FCN
| Kgsthzcf | Ppvvq | $8.1 Bil |
United States